Market Overview

10 Biggest Price Target Changes For Monday

Share:
  • Buckingham Research raised the price target for Valvoline Inc (NYSE: VVV) from $18 to $24. Valvoline shares closed at $19.53 on Friday.
  • Morgan Stanley cut the price target for BOK Financial Corporation (NASDAQ: BOKF) from $94 to $89. BOK Financial shares closed at $75.48 on Friday.
  • Credit Suisse boosted the price target for JinkoSolar Holding Co., Ltd. (NYSE: JKS) from $16 to $18. JinkoSolar shares closed at $21.69 on Friday.
  • SunTrust Robinson Humphrey lowered the price target on GreenSky LLC (NASDAQ: GSKY) from $15 to $11. GreenSky shares closed at $12.29 on Friday.
  • Goldman Sachs lowered SolarWinds Corp (NYSE: SWI) price target from $20 to $17.5. SolarWinds shares closed at $18.34 on Friday.
  • Bank of America raised the price target for Zoetis Inc (NYSE: ZTS) from $111 to $120. Zoetis shares closed at $113.49 on Friday.
  • Barclays cut the price target for SM Energy Co (NYSE: SM) from $18 to $13. SM Energy shares closed at $12.52 on Friday.
  • Berenberg lowered Carnival Corp (NYSE: CCL) price target from $60 to $48. Carnival shares closed at $46.55 on Friday.
  • Goldman Sachs raised the price target on Anaplan Inc (NYSE: PLAN) from $48 to $62. Anaplan shares closed at $50.47 on Friday.
  • Baird boosted Generac Holdings Inc. (NYSE: GNRC) price target from $64 to $86. Generac shares closed at $69.41 on Friday.

Posted-In: Price Target ChangesPrice Target Intraday Update Analyst Ratings

 

Related Articles (BOKF + CCL)

View Comments and Join the Discussion!

Latest Ratings

StockFirmActionPT
IQDowngrades
IQDowngrades21.0
COTYMaintains9.0
FNMaintains60.0
NNNMaintains57.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com

Ceasefire: Tariff Tailwind Injects Early Euphoria, With New Record Highs In Sight

Bicycle Therapeutics Trades Higher On Positive Early-Stage Trial Results For Diabetic Macular Edema Therapy